Clinical Trial Update: Celecoxib in Treating Patients With Early-Stage Rectal Cancer [NA]

View source ↗

Summary

The clinical trial evaluating celecoxib for early-stage rectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Colorectal Cancer | NA | Status: TERMINATED